DDRE-34. TRIBBLES-1 (TRIB1) PSEUDOKINASE PROMOTES SURVIVAL OF GBM CELLS BY DECREASING RT/TMZ INDUCED APOPTOSIS

INTRODUCTION: Glioblastoma (GBM) is the most aggressive form of glioma with a mean survival of 12 to 15 months after diagnosis. The current therapy involves administration of radiation therapy and temozolomide (TMZ). Due to poor survival outcome, new druggable therapeutic targets need to be identifi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Singh, Karnika, Han, Chunhua, Fleming, Jessica, McElroy, Joseph, Bell, Erica, Robe, Pierre, Haque, S Jaharul, Chakravarti, Arnab
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Drug Discovery, Drug Resistance
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651042/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.279
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller